TOPCO SCIENTIFIC CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 258 TWD | +0.39% |
|
+3.41% | +41.37% |
| May. 03 | Topco Scientific Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 16 | Taiwan appoints senior executive at TSMC supplier as new economy minister | RE |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 19,169 | 21,713 | 28,709 | 29,799 | 34,438 | 48,684 | - |
| Enterprise Value (EV) 1 | 17,449 | 19,891 | 26,931 | 27,021 | 33,018 | 45,481 | 43,803 |
| P/E ratio | 11.2 x | 10.6 x | 12.6 x | 9.99 x | 11.9 x | 16 x | 13.6 x |
| Yield | 6.16% | 6.69% | 5.57% | 6.1% | 4.93% | 4.02% | 4.55% |
| Capitalization / Revenue | 0.6 x | 0.6 x | 0.67 x | 0.56 x | 0.7 x | 0.9 x | 0.8 x |
| EV / Revenue | 0.55 x | 0.55 x | 0.63 x | 0.51 x | 0.67 x | 0.84 x | 0.72 x |
| EV / EBITDA | 8.23 x | 8.39 x | 9.18 x | 7.33 x | 8.98 x | 11.4 x | 9.58 x |
| EV / FCF | 12.1 x | 11.5 x | 12.3 x | 9.6 x | 27 x | 13.9 x | 12.2 x |
| FCF Yield | 8.28% | 8.72% | 8.14% | 10.4% | 3.7% | 7.17% | 8.2% |
| Price to Book | 2.02 x | 2.05 x | 2.48 x | 2.3 x | 2.28 x | 3.03 x | 2.74 x |
| Nbr of stocks (in thousands) | 181,700 | 181,700 | 181,700 | 181,700 | 188,700 | 188,700 | - |
| Reference price 2 | 105.5 | 119.5 | 158.0 | 164.0 | 182.5 | 258.0 | 258.0 |
| Announcement Date | 3/26/20 | 3/29/21 | 3/15/22 | 3/13/23 | 3/1/24 | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 31,701 | 36,168 | 42,669 | 52,978 | 49,273 | 54,238 | 61,038 |
| EBITDA 1 | 2,121 | 2,369 | 2,932 | 3,686 | 3,677 | 3,996 | 4,572 |
| EBIT 1 | 1,845 | 2,062 | 2,552 | 3,230 | 3,198 | 3,637 | 4,277 |
| Operating Margin | 5.82% | 5.7% | 5.98% | 6.1% | 6.49% | 6.71% | 7.01% |
| Earnings before Tax (EBT) 1 | 2,208 | 2,559 | 3,040 | 4,242 | 3,880 | 4,184 | 4,901 |
| Net income 1 | 1,722 | 2,068 | 2,294 | 3,018 | 2,835 | 3,029 | 3,537 |
| Net margin | 5.43% | 5.72% | 5.38% | 5.7% | 5.75% | 5.58% | 5.79% |
| EPS 2 | 9.420 | 11.29 | 12.53 | 16.41 | 15.36 | 16.17 | 18.96 |
| Free Cash Flow 1 | 1,446 | 1,734 | 2,191 | 2,815 | 1,223 | 3,262 | 3,593 |
| FCF margin | 4.56% | 4.79% | 5.14% | 5.31% | 2.48% | 6.01% | 5.89% |
| FCF Conversion (EBITDA) | 68.15% | 73.17% | 74.74% | 76.37% | 33.26% | 81.64% | 78.58% |
| FCF Conversion (Net income) | 83.93% | 83.82% | 95.51% | 93.26% | 43.14% | 107.69% | 101.58% |
| Dividend per Share 2 | 6.500 | 8.000 | 8.800 | 10.00 | 9.000 | 10.38 | 11.75 |
| Announcement Date | 3/26/20 | 3/29/21 | 3/15/22 | 3/13/23 | 3/1/24 | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 11,766 | 12,583 | 13,225 | 13,793 | 13,377 | 12,492 | 12,055 | 12,492 | 12,233 | 11,932 | 12,911 | 14,421 | 14,898 | 13,484 | 14,167 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 730.8 | 714.4 | 778.9 | 977.9 | 758.7 | 711.7 | 732.9 | 947 | 806.6 | 874.6 | 809.7 | 1,017 | 1,075 | 836 | 917 |
| Operating Margin | 6.21% | 5.68% | 5.89% | 7.09% | 5.67% | 5.7% | 6.08% | 7.58% | 6.59% | 7.33% | 6.27% | 7.05% | 7.22% | 6.2% | 6.47% |
| Earnings before Tax (EBT) 1 | 866.5 | 916.3 | 1,188 | 1,229 | 907.9 | 950.5 | 956.7 | 1,065 | 908 | 1,054 | 965 | 1,143 | 1,198 | 1,039 | 1,109 |
| Net income 1 | 633.2 | 659.9 | 900.3 | 893.2 | 565.1 | 739.9 | 669.6 | 791.9 | 633.6 | 775 | 699.3 | 848.3 | 838 | 798 | 796 |
| Net margin | 5.38% | 5.24% | 6.81% | 6.48% | 4.22% | 5.92% | 5.55% | 6.34% | 5.18% | 6.5% | 5.42% | 5.88% | 5.63% | 5.92% | 5.62% |
| EPS 2 | 3.450 | 3.610 | 4.920 | 4.870 | 3.050 | 4.030 | 3.670 | 4.250 | 3.350 | 4.110 | 3.737 | 4.533 | 4.473 | 4.230 | 4.220 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/15/22 | 4/29/22 | 7/29/22 | 10/28/22 | 3/13/23 | 5/5/23 | 7/27/23 | 11/1/23 | 3/1/24 | 5/3/24 | - | - | - | - | - |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | 1,721 | 1,822 | 1,778 | 2,778 | 1,419 | 3,203 | 4,881 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 1,446 | 1,734 | 2,191 | 2,815 | 1,223 | 3,262 | 3,593 |
| ROE (net income / shareholders' equity) | 19.1% | 20.6% | 20.7% | 24.6% | 20.2% | 20.7% | 21.1% |
| ROA (Net income/ Total Assets) | 9.34% | 10.1% | 9.84% | 11% | 9.22% | 10.7% | 11% |
| Assets 1 | 18,439 | 20,546 | 23,313 | 27,527 | 30,758 | 28,308 | 32,155 |
| Book Value Per Share 2 | 52.40 | 58.20 | 63.80 | 71.30 | 80.10 | 85.10 | 94.30 |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | 312 | 273 | 406 | 369 | 398 | 369 | 369 |
| Capex / Sales | 0.99% | 0.75% | 0.95% | 0.7% | 0.81% | 0.68% | 0.6% |
| Announcement Date | 3/26/20 | 3/29/21 | 3/15/22 | 3/13/23 | 3/1/24 | - | - |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
258
TWD
Average target price
236
TWD
Spread / Average Target
-8.53%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +41.37% | 1.5B | |
| +81.49% | 2,212B | |
| +35.24% | 641B | |
| +3.06% | 246B | |
| +25.89% | 203B | |
| +9.73% | 170B | |
| +42.07% | 134B | |
| -40.60% | 127B | |
| +44.84% | 112B | |
| +4.35% | 103B |
- Stock Market
- Equities
- 5434 Stock
- Financials Topco Scientific Co.,Ltd.
